TECON(SZ:002100)2025-05-23 10:20Group 1: Company Financials and Plans - The company currently has no share repurchase plan but will disclose any future plans in accordance with regulations [2] - As of May 20, 2025, the number of shareholders is 73,557 [3] - The company achieved a net profit of 148 million yuan in Q1 2025 and aims to meet its annual business targets [5] Group 2: Dividend and Profit Distribution - There is no mid-term dividend plan for 2025 as of now [2] - The profit distribution for 2024 will be implemented within two months after the annual shareholders' meeting [3] Group 3: Business Operations and Market Strategy - The company is focused on feed production, veterinary drug development, pig farming, and agricultural product processing, with no current plans to enter the pet economy [3] - The company plans to raise its pig output from 3.0285 million heads in 2024 to between 3.5 million and 4 million heads in 2025 [5] Group 4: Management and Incentive Policies - The increase in management expenses from 487 million yuan in 2023 to 560 million yuan in 2024 is due to depreciation from newly added fixed assets, not due to increased management salaries [3] - The company is reviewing its incentive policies to ensure they align with shareholder interests, especially in light of recent losses [6] Group 5: Market and Shareholder Communication - The company emphasizes value management through shareholding increases by major shareholders and improved governance and communication with investors [4] - The company is in the process of listing its pharmaceutical division on the Beijing Stock Exchange, with timelines dependent on regulatory reviews [5]